Applications of bile acids as biomaterials-based modulators, in biomedical science and microfluidics.
Wee Ling KohThomas FosterArmin MooranianHani Al-SalamiPublished in: Therapeutic delivery (2023)
Chronic disorders such as diabetes mellitus are associated with multiple organ dysfunction, including retinopathy, neuropathy, nephropathy, peripheral vascular disease, and vascular disease. Lifelong subcutaneous insulin injections are currently the only treatment option for patients with Type 1 diabetes mellitus, and it poses numerous challenges. Since the breakthrough achieved from the Edmonton protocol in the year 2000, there has been important research to investigate whether islet cell transplantation can achieve long-term normoglycemia in patients without the need for insulin. The use of biopolymeric scaffold to enclose islet cells has also been explored to improve survivability and viability of islet cells. This review paper summarizes the latest research in using biopolymeric scaffolds in islet transplantation and how microfluidic devices can assist.
Keyphrases
- end stage renal disease
- type diabetes
- induced apoptosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- single cell
- randomized controlled trial
- public health
- cell therapy
- stem cells
- mesenchymal stem cells
- small molecule
- cell cycle arrest
- tissue engineering
- metabolic syndrome
- signaling pathway
- patient reported outcomes
- adipose tissue
- ultrasound guided
- endoplasmic reticulum stress
- bone marrow
- drug induced
- pi k akt